SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001308179-23-000758
Filing Date
2023-04-24
Accepted
2023-04-24 16:32:21
Documents
6

Document Format Files

Seq Description Document Type Size
1 ULTRAGENYX PHARMACEUTICAL INC. - DEFA14A lrare2023_defa14a.htm DEFA14A 9290
2 GRAPHIC check01.jpg GRAPHIC 1645
3 GRAPHIC logo.jpg GRAPHIC 14880
4 GRAPHIC notice1.jpg GRAPHIC 354746
5 GRAPHIC notice2.jpg GRAPHIC 214030
6 GRAPHIC uncheck.jpg GRAPHIC 1060
  Complete submission text file 0001308179-23-000758.txt   818411
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36276 | Film No.: 23840506
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences